Blogs

Tags

Strategic Valuation Realignment in a United States Healthcare Company: Governance-Driven Advisory in a Shareholder Conflict Blog— AABDCEGYPT Flagship Case Study

Strategic Valuation Realignment in a United States Healthcare Company: Governance-Driven Advisory in a Shareholder Conflict Blog— AABDCEGYPT Flagship Case Study

By Ahmed Amer — AABDCEGYPT

Flagship case study on governance-driven valuation realignment in a U.S. healthcare company using EBITDA normalization and market-aligned frameworks.
27.02.26 07:26 AM - Comment(s)
EV/EBITDA and Adjusted EBITDA: Building a Defensible Market Based Company Valuation

EV/EBITDA and Adjusted EBITDA: Building a Defensible Market Based Company Valuation

By Ahmed Amer — AABDCEGYPT

EV/EBITDA and Adjusted EBITDA explained through normalization, comparable multiples, enterprise value, equity value, and defensible market based valuation.
16.02.26 02:12 AM - Comment(s)
Company Valuation in 2026: Market, Income, and Asset Based Approaches for Defensible Value

Company Valuation in 2026: Market, Income, and Asset Based Approaches for Defensible Value

By Ahmed Amer — AABDCEGYPT

Company valuation in 2026 explained through market, income, and asset based approaches, Adjusted EBITDA, DCF, enterprise value, and equity value.
15.02.26 02:59 AM - Comment(s)
When to Stop Growing: A Business Development Decision Leaders Avoid

When to Stop Growing: A Business Development Decision Leaders Avoid

By Ahmed Amer — AABDCEGYPT

Know when to continue, pause, reset, reduce, or exit a growth initiative based on evidence, economics, capacity, liquidity, and opportunity cost.
11.02.26 03:00 PM - Comment(s)
The Hidden Cost of Unstructured Growth Initiatives

The Hidden Cost of Unstructured Growth Initiatives

By Ahmed Amer — AABDCEGYPT

Explore how unstructured growth initiatives create resource fragmentation, coordination cost, leadership overload, and hidden organizational risk.
09.02.26 09:00 AM - Comment(s)